Neuroimmunology News and Research

RSS
Researchers document pathological progress of multiple sclerosis

Researchers document pathological progress of multiple sclerosis

Griffith researcher awarded $1.85m grant to accelerate diagnosis, treatment for CFS

Griffith researcher awarded $1.85m grant to accelerate diagnosis, treatment for CFS

New MS treatment found safe, tolerable in phase I clinical trials

New MS treatment found safe, tolerable in phase I clinical trials

New specialised clinic, smartphone app aim to improve health outcomes of chronic fatigue patients

New specialised clinic, smartphone app aim to improve health outcomes of chronic fatigue patients

Noninvasive optical imaging device helps to detect changes linked with Alzheimer's disease

Noninvasive optical imaging device helps to detect changes linked with Alzheimer's disease

Scientists report first successful step toward vaccine that targets mutation in brain cancer

Scientists report first successful step toward vaccine that targets mutation in brain cancer

People with CFS to benefit from Griffith’s National Centre for Neuroimmunology and Emerging Diseases

People with CFS to benefit from Griffith’s National Centre for Neuroimmunology and Emerging Diseases

Revalesio to conduct RNS60 Phase IIa clinical trial in RRMS patients

Revalesio to conduct RNS60 Phase IIa clinical trial in RRMS patients

Publication provides update on the origins and causes of anxiety disorders

Publication provides update on the origins and causes of anxiety disorders

Biochemists discover promising vitamin D-based treatment that halts or reverse MS

Biochemists discover promising vitamin D-based treatment that halts or reverse MS

Biochemists discover promising vitamin D-based treatment that can halt MS

Biochemists discover promising vitamin D-based treatment that can halt MS

LMU immunologists develop new technique to fight against tumors, autoimmune diseases

LMU immunologists develop new technique to fight against tumors, autoimmune diseases

Argentina's ANMAT approves AUBAGIO for patients with relapsing multiple sclerosis

Argentina's ANMAT approves AUBAGIO for patients with relapsing multiple sclerosis

Study reveals increased dietary salt intake may lead to autoimmune disorders

Study reveals increased dietary salt intake may lead to autoimmune disorders

NSU-COM to hold grand opening for America's first Institute for Neuro Immune Medicine

NSU-COM to hold grand opening for America's first Institute for Neuro Immune Medicine

Myasthenia gravis therapies: an interview with Professor Daniel Drachman

Myasthenia gravis therapies: an interview with Professor Daniel Drachman

Mayo researchers discover new therapy for patients with neuromyelitis optica

Mayo researchers discover new therapy for patients with neuromyelitis optica

Autoimmune disease myasthenia gravis halted in mice

Autoimmune disease myasthenia gravis halted in mice

MitoTarget Project and neurodegenerative diseases: an interview with Rebecca Pruss, Ph.D., CSO of Trophos

MitoTarget Project and neurodegenerative diseases: an interview with Rebecca Pruss, Ph.D., CSO of Trophos

DFG to set up new CRC/Transregio that focuses on multiple sclerosis research

DFG to set up new CRC/Transregio that focuses on multiple sclerosis research